Profile data is unavailable for this security.
About the company
bioAffinity Technologies, Inc. is a biotechnology company focused on the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments. It develops noninvasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis developed by machine learning, a form of artificial intelligence (AI). The Company’s product, CyPath Lung, is a noninvasive test that has shown high sensitivity, specificity and accuracy for the detection of early-stage lung cancer. CyPath is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Laboratory Services, a subsidiary of the Company. CyPath Lung uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor.
- Revenue in USD (TTM)6.78m
- Net income in USD-14.74m
- Incorporated2014
- Employees57.00
- LocationbioAffinity Technologies Inc3300 Nacogdoches Road, Suite 216SAN ANTONIO 78217United StatesUSA
- Phone+1 (210) 698-5334
- Fax+1 (916) 443-1908
- Websitehttps://bioaffinitytech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Work Medical Technology Group Ltd | 10.74m | -3.71m | 2.81m | 229.00 | -- | 0.0002 | -- | 0.2617 | -2,871.58 | -2,871.58 | 7,811.59 | 8,868.19 | -- | -- | -- | 46,903.67 | -- | -- | -- | -- | 26.89 | -- | -35.42 | -- | 0.9802 | -8.87 | 0.4505 | -- | -15.18 | -- | -3,217.31 | -- | -- | -- |
| ENvue Medical Inc | 2.69m | -5.21m | 2.95m | 15.00 | -- | 0.0645 | -- | 1.10 | -83.93 | -83.93 | 7.46 | 42.00 | 0.0909 | 0.8364 | 6.45 | 179,000.00 | -25.01 | -97.63 | -32.90 | -149.18 | 30.02 | 53.04 | -275.12 | -397.83 | 0.6675 | -- | 0.0669 | -- | 12.05 | 37.00 | 0.1617 | -- | -- | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 2.96m | 31.00 | 1.11 | -- | 0.8014 | 0.1606 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
| Catheter Precision Inc | 730.00k | -22.19m | 3.17m | 22.00 | -- | 0.4614 | -- | 4.34 | -37.38 | -37.38 | 0.9371 | 4.12 | 0.028 | 1.64 | 6.35 | 33,181.82 | -66.93 | -128.03 | -78.29 | -160.12 | 92.60 | -242.70 | -2,393.84 | -15,268.88 | 0.4569 | -66.84 | 0.0449 | -- | -4.98 | -19.89 | 69.45 | -- | -24.21 | -- |
| Encision Inc | 6.30m | -380.94k | 3.19m | 22.00 | -- | 1.71 | -- | 0.5061 | -0.0284 | -0.0284 | 0.5057 | 0.1105 | 1.66 | 2.27 | 7.98 | 286,353.60 | -10.05 | -3.17 | -14.19 | -4.40 | 52.64 | 51.47 | -6.05 | -2.01 | 0.9127 | -5.69 | 0.1094 | -- | -0.464 | -3.09 | 68.17 | -- | 8.09 | -- |
| Avalon Globocare Corp | 1.40m | -18.76m | 3.52m | 5.00 | -- | -- | -- | 2.52 | -9.75 | -9.75 | 0.6074 | -1.10 | 0.0974 | -- | 16.92 | 279,216.00 | -131.94 | -76.04 | -1,379.37 | -114.37 | 25.70 | 23.19 | -1,355.20 | -888.89 | 0.1477 | -4.07 | 2.69 | -- | 6.19 | -2.92 | 52.69 | -- | -- | -- |
| Profusa Inc | 0.00 | -39.09m | 3.62m | 0.00 | -- | -- | -- | -- | -278.73 | -278.73 | 0.00 | -61.05 | 0.00 | -- | -- | -- | -599.88 | -- | -- | -- | -- | -- | -- | -- | -- | -14.56 | -- | -- | -- | -- | -849.77 | -- | -- | -- |
| Vycor Medical Inc | 1.90m | -338.88k | 3.67m | 7.00 | -- | -- | -- | 1.93 | -0.0103 | -0.0103 | 0.0548 | -0.1206 | 1.89 | 1.57 | 6.73 | 271,678.60 | -1.44 | -36.90 | -- | -- | 85.35 | 89.43 | -0.7625 | -26.12 | 0.1028 | 0.8609 | -- | -- | 8.81 | 2.67 | -11.32 | -- | -40.90 | -- |
| Reflect Scientific Inc | 1.72m | -29.42k | 4.10m | 7.00 | -- | 1.97 | 21.95 | 2.38 | -0.0004 | -0.0004 | 0.0201 | 0.0243 | 0.6826 | 0.8429 | 8.78 | 245,945.70 | -1.17 | 11.10 | -1.32 | 13.21 | 58.47 | 62.48 | -1.71 | 10.00 | 9.46 | -- | 0.00 | -- | -47.09 | -6.99 | -613.46 | -- | -- | -- |
| Nuwellis Inc | 8.17m | -16.56m | 4.14m | 38.00 | -- | 0.7719 | -- | 0.5070 | -107.66 | -107.66 | 26.64 | 2.87 | 1.11 | 1.65 | 6.71 | 214,947.40 | -225.22 | -87.78 | -390.32 | -108.53 | 59.07 | 57.73 | -202.83 | -195.83 | 1.42 | -1.05 | 0.00 | -- | -1.40 | 9.66 | 53.05 | -- | -34.30 | -- |
| bioAffinity Technologies Inc | 6.78m | -14.74m | 4.47m | 57.00 | -- | 0.3867 | -- | 0.6592 | -20.74 | -20.74 | 9.34 | 2.57 | 0.7489 | 161.37 | 7.97 | 118,890.20 | -162.88 | -- | -222.52 | -- | 27.86 | -- | -217.50 | -- | 3.64 | -2.69 | 0.0332 | -- | 269.68 | -- | -13.89 | -- | -- | -- |
| Axim Biotechnologies Inc | 92.90k | -4.14m | 4.59m | 6.00 | -- | -- | -- | 49.46 | -0.0163 | -0.0163 | 0.0003 | -0.0324 | 0.0233 | -- | -- | 15,483.33 | -103.73 | -154.34 | -- | -390.73 | 16.94 | -- | -4,451.97 | -36,362.71 | -- | -3.14 | -- | -- | 345.05 | -27.38 | -29.10 | -- | -- | -- |
| Dalrada Financial Corp | 18.37m | -23.89m | 4.69m | 0.00 | -- | -- | -- | 0.2551 | -0.2172 | -0.2172 | 0.1626 | -0.1303 | 0.9089 | 4.86 | 5.34 | -- | -118.42 | -100.15 | -1,575.08 | -1,511.45 | 25.57 | 28.94 | -130.29 | -92.98 | 0.2685 | -6.36 | -- | -- | 2.32 | 76.71 | 14.86 | -- | 15.56 | -- |
| Co-Diagnostics Inc | 507.90k | -32.18m | 4.77m | 132.00 | -- | 0.0947 | -- | 9.39 | -29.44 | -29.44 | 0.4551 | 24.82 | 0.0087 | 0.2844 | 4.34 | 3,847.73 | -54.95 | -1.67 | -59.80 | -1.78 | 34.03 | 82.14 | -6,336.17 | -3.71 | 3.51 | -- | 0.00 | -- | -42.53 | 78.68 | -6.53 | -- | 45.89 | -- |
| ADM Tronics Unlimited Inc | 3.36m | -129.58k | 4.80m | 7.00 | -- | 5.45 | 13.65 | 1.43 | -0.0019 | -0.0019 | 0.0497 | 0.013 | 1.47 | 4.95 | 6.60 | -- | -5.67 | -17.71 | -10.33 | -27.75 | 39.07 | 40.78 | -3.86 | -19.08 | 0.8633 | -3.74 | 0.3461 | -- | 7.81 | -1.72 | 85.97 | -- | -- | -- |
| Innovative Eyewear Inc | 2.39m | -7.85m | 5.89m | 11.00 | -- | 0.5587 | -- | 2.46 | -2.63 | -2.63 | 0.7369 | 1.97 | 0.2101 | 1.45 | 29.13 | 217,504.50 | -68.92 | -143.06 | -73.91 | -176.80 | 22.84 | 4.06 | -327.98 | -574.89 | 10.13 | -- | 0.00 | -- | 41.99 | 220.75 | -16.55 | -- | -- | -- |
Data as of Feb 12 2026. Currency figures normalised to bioAffinity Technologies Inc's reporting currency: US Dollar USD
9.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sabby Management LLCas of 30 Sep 2025 | 242.76k | 5.40% |
| District 2 Capital LPas of 29 Sep 2025 | 117.36k | 2.61% |
| Abante Asesores Gesti�n SGIIC SAas of 31 Dec 2025 | 43.17k | 0.96% |
| Scientech Research LLCas of 30 Sep 2025 | 16.58k | 0.37% |
| Tower Research Capital LLCas of 30 Sep 2025 | 2.50k | 0.06% |
| BofA Securities, Inc.as of 30 Sep 2025 | 1.68k | 0.04% |
| IFP Advisors LLCas of 31 Dec 2025 | 833.00 | 0.02% |
| Citigroup Global Markets, Inc. (Investment Management)as of 30 Sep 2025 | 75.00 | 0.00% |
| Strategic Advisers LLCas of 30 Sep 2025 | 26.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 30 Sep 2025 | 6.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
